Exponent, Inc. (EXPO) Given Average Rating of “Buy” by Brokerages
Exponent, Inc. (NASDAQ:EXPO) has earned an average broker rating score of 2.33 (Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. Two investment analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company.
Brokerages have set a 1-year consensus price target of $79.50 for the company and are anticipating that the company will post $0.41 earnings per share for the current quarter, according to Zacks. Zacks has also given Exponent an industry rank of 71 out of 265 based on the ratings given to its competitors.
A number of equities research analysts recently commented on EXPO shares. Zacks Investment Research upgraded Exponent from a “hold” rating to a “buy” rating and set a $74.00 target price on the stock in a research report on Thursday, July 20th. Cantor Fitzgerald restated a “buy” rating and set a $75.00 price objective on shares of Exponent in a research report on Thursday, August 31st. ValuEngine upgraded Exponent from a “sell” rating to a “hold” rating in a research report on Thursday, July 20th. Finally, SunTrust Banks, Inc. restated a “hold” rating and set a $77.00 price objective on shares of Exponent in a research report on Thursday, October 19th.
TRADEMARK VIOLATION NOTICE: “Exponent, Inc. (EXPO) Given Average Rating of “Buy” by Brokerages” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/05/exponent-inc-expo-given-average-rating-of-buy-by-brokerages.html.
Shares of Exponent (NASDAQ EXPO) opened at $73.55 on Friday. The company has a market capitalization of $1,897.08, a PE ratio of 40.19 and a beta of 0.58. Exponent has a 52-week low of $55.75 and a 52-week high of $77.15.
Exponent (NASDAQ:EXPO) last posted its earnings results on Wednesday, October 18th. The business services provider reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.09. The company had revenue of $87.60 million for the quarter, compared to the consensus estimate of $79.69 million. Exponent had a return on equity of 17.21% and a net margin of 16.46%. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.42 earnings per share. analysts expect that Exponent will post 2.09 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 22nd. Shareholders of record on Friday, December 1st will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $0.84 dividend on an annualized basis and a yield of 1.14%. Exponent’s dividend payout ratio (DPR) is presently 40.98%.
In other Exponent news, CEO Paul R. Johnston sold 3,052 shares of the company’s stock in a transaction that occurred on Tuesday, September 26th. The stock was sold at an average price of $73.11, for a total transaction of $223,131.72. Following the sale, the chief executive officer now directly owns 35,342 shares in the company, valued at $2,583,853.62. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Paul R. Johnston sold 3,000 shares of the company’s stock in a transaction that occurred on Friday, September 29th. The shares were sold at an average price of $74.01, for a total value of $222,030.00. Following the sale, the chief executive officer now owns 32,342 shares in the company, valued at $2,393,631.42. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 54,851 shares of company stock worth $3,710,760. Company insiders own 2.80% of the company’s stock.
A number of hedge funds have recently modified their holdings of the business. Alps Advisors Inc. grew its stake in shares of Exponent by 0.3% during the second quarter. Alps Advisors Inc. now owns 8,206 shares of the business services provider’s stock valued at $478,000 after buying an additional 21 shares during the last quarter. Bank of Montreal Can grew its stake in shares of Exponent by 0.7% during the second quarter. Bank of Montreal Can now owns 3,231 shares of the business services provider’s stock valued at $189,000 after buying an additional 22 shares during the last quarter. Pinebridge Investments L.P. grew its stake in shares of Exponent by 2.1% during the second quarter. Pinebridge Investments L.P. now owns 3,409 shares of the business services provider’s stock valued at $199,000 after buying an additional 70 shares during the last quarter. UBS Group AG grew its stake in shares of Exponent by 0.3% during the first quarter. UBS Group AG now owns 36,673 shares of the business services provider’s stock valued at $2,184,000 after buying an additional 98 shares during the last quarter. Finally, Louisiana State Employees Retirement System grew its stake in shares of Exponent by 1.0% during the second quarter. Louisiana State Employees Retirement System now owns 10,500 shares of the business services provider’s stock valued at $612,000 after buying an additional 100 shares during the last quarter. Institutional investors and hedge funds own 88.67% of the company’s stock.
Exponent Company Profile
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.